Shachar Kenan

Dr. Shachar Kenan

orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 1992 in Clinical Radiology
Verified
Journal Article
Closed access
IAI.F. Abdelwahab
I.F. Abdelwahab
Shachar KenanShachar Kenan
Shachar Kenan
MKMichael Jeffrey Klein
Michael Jeffrey Klein
MLM.M. Lewis
M.M. Lewis

15 March 2021 in Sarcoma
Verified
Journal Article
Open access
PDF file
MBMeredith K. Bartelstein
Meredith K. Bartelstein
DYDivya Yerramilli
Divya Yerramilli
ACAlexander Bryant Christ
Alexander Bryant Christ
Shachar KenanShachar Kenan
Shachar Kenan
KOKOICHI OGURA
KOICHI OGURA
JHJohn Healey
John Healey
Soft tissue sarcoma (STS) of the extremities is typically treated with limb-sparing surgery and radiation therapy; with this treatment approach, high local control rates can be achieved. However, postradiation bone fractures, fractures occurring in the prior radiation field with minimal or no trauma, are a serious late complication that occurs in 2–22% of patients who receive surgery and radiation for STS. Multiple risk factors for sustaining a postradiation fracture exist, including high radiation dose, female sex, periosteal stripping, older age, femur location, and chemotherapy administration. The treatment of these pathological fractures can be difficult, with complications including delayed union, nonunion, and infection posing particular challenges. Here, we review the mechanisms, risk factors, and treatment challenges associated with postradiation fractures in STS patients.

29 March 2016 in Skeletal Radiology
Verified
Journal Article
Closed access
PDF file
Shachar KenanShachar Kenan
Shachar Kenan
LKLeonard Kahn
Leonard Kahn
NHNoga Haramati
Noga Haramati
SKSamuel Kenan
Samuel Kenan

1 April 2021 in Bone & Joint Open
Verified
Journal Article
Open access
MFMichael J. Fitzgerald
Michael J. Fitzgerald
HGHoward J. Goodman
Howard J. Goodman
SKSamuel Kenan
Samuel Kenan
Shachar KenanShachar Kenan
Shachar Kenan
Aims: The aim of this study was to assess orthopaedic oncologic patient morbidity resulting from COVID-19 related institutional delays and surgical shutdowns during the first wave of the pandemic in New York, USA. Methods: A single-centre retrospective observational study was conducted of all orthopaedic oncologic patients undergoing surgical evaluation from March to June 2020. Patients were prioritized as level 0-IV, 0 being elective and IV being emergent. Only priority levels 0 to III were included. Delay duration was measured in days and resulting morbidities were categorized into seven groups: prolonged pain/disability; unplanned preoperative radiation and/or chemotherapy; local tumour progression; increased systemic disease; missed opportunity for surgery due to progression of disease/lost to follow up; delay in diagnosis; and no morbidity. Results: Overall, 25 patients met inclusion criteria. There were eight benign tumours, seven metastatic, seven primary sarcomas, one multiple myeloma, and two patients without a biopsy proven diagnosis. There was no priority level 0, two priority level I, six priority level II, and 17 priority level III cases. The mean duration of delay for priority level I was 114 days (84 to 143), priority level II was 88 days (63 to 133), and priority level III was 77 days (35 to 269). Prolonged pain/disability and delay in diagnosis, affecting 52% and 40%,respectively, represented the two most frequent morbidities. Local tumour progression and increased systemic disease affected 32% and 24% respectively. No patients tested positive for COVID-19. Conclusion: COVID-19 related delays in surgical management led to major morbidity in this studied orthopaedic oncologic patient population. By understanding these morbidities through clearer hindsight, a thoughtful approach can be developed to balance the risk of COVID-19 exposure versus delay in treatment, ensuring optimal care for orthopedic oncologic patients as the pandemic continues with intermittent calls for halting surgery. Cite this article: Bone Jt Open 2021;2(4):236–242.

1 November 2020 in Journal of Orthopaedics
Verified
Journal Article
Closed access
CLChristopher G. Larsen
Christopher G. Larsen
WCWilliam K. Crockatt
William K. Crockatt
MFMichael Fitzgerald
Michael Fitzgerald
NMNanette Matos
Nanette Matos
HGHoward J. Goodman
Howard J. Goodman
Shachar KenanShachar Kenan
Shachar Kenan

16 April 1997 in Skeletal Radiology
Verified
Journal Article
Closed access
PDF file
IAIbrahim F. Abdelwahab
Ibrahim F. Abdelwahab
Shachar KenanShachar Kenan
Shachar Kenan
GHGeorge Hermann
George Hermann
MKMichael J. Klein
Michael J. Klein